Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vulvo Vaginal Atrophy (VVA)”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Post-approval studies (Phase 4)Study completedNCT02784613
What this trial is testing

Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA

Who this might be right for
Vulvovaginal AtrophyDyspareunia
Sue Goldstein 10
Testing effectiveness (Phase 2)Study completedNCT02449902
What this trial is testing

TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy

Who this might be right for
MenopauseVulvovaginal AtrophyPainful Intercourse+1 more
TherapeuticsMD 50
Large-scale testing (Phase 3)Study completedNCT02013544
What this trial is testing

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause

Who this might be right for
Vaginal Atrophy
EndoCeutics Inc. 558
Testing effectiveness (Phase 2)Study completedNCT04222647
What this trial is testing

Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA

Who this might be right for
Vulvovaginal Atrophy
Dr. August Wolff GmbH & Co. KG Arzneimittel 43
Large-scale testing (Phase 3)Study completedNCT02253173
What this trial is testing

Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women

Who this might be right for
Vulvovaginal AtrophyMenopauseDyspareunia+1 more
TherapeuticsMD 764
Not applicableUnknownNCT03823560
What this trial is testing

Performance and Safety of Class IIb MD Celegyn® in VVA

Who this might be right for
Vulvovaginal Atrophy
Nathura S.p.A 96
Testing effectiveness (Phase 2)Looking for participantsNCT06197568
What this trial is testing

Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women

Who this might be right for
Vulvo Vaginal Atrophy (VVA)
Azure Biotech Inc. 90
Not applicableLooking for participantsNCT07024667
What this trial is testing

Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vaginal Atrophy

Who this might be right for
Vulvar AtrophyVaginal Atrophy
Hillel Yaffe Medical Center 20
Large-scale testing (Phase 3)WithdrawnNCT03740945
What this trial is testing

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Who this might be right for
Vaginal Atrophy in Breast Cancer Patients
EndoCeutics Inc.
Large-scale testing (Phase 3)Study completedNCT02638337
What this trial is testing

Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause

Who this might be right for
Vaginal Dryness
Shionogi 631
Not applicableActive Not RecruitingNCT07367061
What this trial is testing

Clinical Investigation to Assess Safety and Efficacy of INNEA AQUA in Adult Women With Vulvo-Vaginal Atrophy (VVA)

Who this might be right for
Vulvo Vaginal Atrophy
Innate srl 62
Not applicableStudy completedNCT04887701
What this trial is testing

Non-hormonal Medical Device for Treatment of Vulvovaginal Atrophy (VVA) in Post-Menopausal Women

Who this might be right for
Vulvovaginal Atrophy
Madorra 25
Not applicableStudy completedNCT02747641
What this trial is testing

Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects

Who this might be right for
AtrophyVaginal AtrophyGenital Diseases, Female
Alma Lasers Inc. 15
Not applicableActive Not RecruitingNCT04081805
What this trial is testing

LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)

Who this might be right for
Vaginal AtrophyVulva; AtrophyBreast Cancer
Federal University of São Paulo 195
Not applicableLooking for participantsNCT06828640
What this trial is testing

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment

Who this might be right for
Vulvo Vaginal AtrophyGenitourinary Syndrome of Menopause (GSM)Vaginal Atrophy in Breast Cancer Patients+4 more
Centre Hospitalier Universitaire Saint Pierre 160
Not applicableEnded earlyNCT03857893
What this trial is testing

New Non-Hormonal Treatment by Radiofrequency for Vulvo-Vaginal Atrophy

Who this might be right for
Vulvo-vaginal AtrophyGenitourinary Syndrome of Menopause
Serge Rozenberg 53
Large-scale testing (Phase 3)Study completedNCT04982692
What this trial is testing

A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy

Who this might be right for
Postmenopausal Vulvovaginal Atrophy
Lee's Pharmaceutical Limited 417